Skip to main content
. 2020 Apr 9;10(4):709. doi: 10.3390/nano10040709

Figure 5.

Figure 5

Viability of BALB/3T3 cells after 24 hours of exposure to ophthalmic formulations A1–A9 and Nevanac at various concentrations and control.